JP2018502574A5 - - Google Patents

Download PDF

Info

Publication number
JP2018502574A5
JP2018502574A5 JP2017535829A JP2017535829A JP2018502574A5 JP 2018502574 A5 JP2018502574 A5 JP 2018502574A5 JP 2017535829 A JP2017535829 A JP 2017535829A JP 2017535829 A JP2017535829 A JP 2017535829A JP 2018502574 A5 JP2018502574 A5 JP 2018502574A5
Authority
JP
Japan
Prior art keywords
cells
human
population
infecting
insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017535829A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018502574A (ja
JP6817943B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2015/051267 external-priority patent/WO2016108237A1/en
Publication of JP2018502574A publication Critical patent/JP2018502574A/ja
Publication of JP2018502574A5 publication Critical patent/JP2018502574A5/ja
Application granted granted Critical
Publication of JP6817943B2 publication Critical patent/JP6817943B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017535829A 2014-12-30 2015-12-30 分化転換方法及びその使用方法 Expired - Fee Related JP6817943B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462098050P 2014-12-30 2014-12-30
US62/098,050 2014-12-30
PCT/IL2015/051267 WO2016108237A1 (en) 2014-12-30 2015-12-30 Methods of transdifferentiation and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2018502574A JP2018502574A (ja) 2018-02-01
JP2018502574A5 true JP2018502574A5 (enExample) 2018-03-15
JP6817943B2 JP6817943B2 (ja) 2021-01-20

Family

ID=56284403

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017535829A Expired - Fee Related JP6817943B2 (ja) 2014-12-30 2015-12-30 分化転換方法及びその使用方法

Country Status (15)

Country Link
US (3) US10179151B2 (enExample)
EP (2) EP3698803B1 (enExample)
JP (1) JP6817943B2 (enExample)
KR (1) KR102487883B1 (enExample)
CN (1) CN107750170B (enExample)
AU (1) AU2015373129B2 (enExample)
BR (1) BR112017014280A2 (enExample)
CA (1) CA2972569A1 (enExample)
CO (1) CO2017006937A2 (enExample)
EA (1) EA035360B1 (enExample)
IL (1) IL253234B (enExample)
MA (1) MA41296A (enExample)
MX (1) MX378321B (enExample)
SG (1) SG11201705344VA (enExample)
WO (1) WO2016108237A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102181336B1 (ko) 2013-06-13 2020-11-24 오르제네시스 엘티디. 세포 집단, 이의 전환분화 방법 및 이용 방법
CA3059017C (en) 2013-09-24 2021-05-25 Giner Life Sciences, Inc. System for gas treatment of a cell implant
MA41296A (fr) 2014-12-30 2017-11-07 Orgenesis Ltd Procédés de transdifférenciation et procédés d'utilisation de ceux-ci
JP6987080B2 (ja) 2016-05-05 2021-12-22 サウスウェスト リサーチ インスティテュート 細胞増殖のための三次元バイオリアクター及び関連用途
JP6993003B2 (ja) 2016-11-15 2022-01-13 ガイナー ライフ サイエンシズ,インク. 皮下インプラントとの使用に適した経皮的ガス拡散装置
EP3618916A4 (en) 2017-05-04 2021-04-14 Giner Life Sciences, Inc. ROBUST IMPLANTABLE GAS DISPENSING DEVICE AND PROCEDURES, SYSTEMS AND DEVICES THEREFORE
WO2018207179A1 (en) 2017-05-08 2018-11-15 Orgenesis Ltd. Transdifferentiated cell populations and methods of use thereof
US20200109370A1 (en) * 2017-05-29 2020-04-09 Orgenesis Ltd. Compositions and methods for providing cell replacement therapy
US20210189352A1 (en) 2017-10-13 2021-06-24 Imba - Institut Für Molekulare Biotechnologie Gmbh Enhanced reprogramming of somatic cells
WO2019171377A1 (en) * 2018-03-06 2019-09-12 Orgenesis Inc Three dimensional clusters of transdifferentiated cells, compositions and methods thereof
US11149244B2 (en) 2018-04-04 2021-10-19 Southwest Research Institute Three-dimensional bioreactor for T-cell activation and expansion for immunotherapy
US11447731B2 (en) 2018-09-24 2022-09-20 Southwest Research Institute Three-dimensional bioreactors
EP3816276A1 (en) * 2019-10-31 2021-05-05 Unicyte Islet AG Viable pancreatic islet-like cell structures and a method of preparing thereof
EP4422787A1 (en) 2021-10-28 2024-09-04 Southwest Research Institute Devices for cell separation

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4980286A (en) 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
US4737323A (en) 1986-02-13 1988-04-12 Liposome Technology, Inc. Liposome extrusion method
DE3751873T2 (de) 1986-04-09 1997-02-13 Genzyme Corp Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US4873316A (en) 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US4992417A (en) 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogues
US5082670A (en) 1988-12-15 1992-01-21 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5328470A (en) 1989-03-31 1994-07-12 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
US5427940A (en) 1991-06-03 1995-06-27 Board Of Regents, The University Of Texas System Engineered cells producing insulin in response to glucose
KR950703640A (ko) 1992-10-09 1995-09-20 가일 케이,나우톤. 간 보존 세포(liver reserve cells)
US5523226A (en) 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
US5424286A (en) 1993-05-24 1995-06-13 Eng; John Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
JP3802051B2 (ja) 1993-08-16 2006-07-26 リサーチ ディベロップメント ファンデーション 膵臓島細胞におけるインシュリン表現を刺激する新しいホメオボックス因子
US5858973A (en) 1994-02-23 1999-01-12 The General Hospital Corporation Transcription factor and uses therefor
IL114193A (en) 1994-06-20 2000-02-29 Teva Pharma Ophthalmic pharmaceutical compositions based on sodium alginate
US5849989A (en) 1994-10-07 1998-12-15 Ontogeny, Inc. Insulin promoter factor, and uses related thereto
NZ324951A (en) 1995-11-30 1999-04-29 Res Dev Foundation Screening assay for compounds stimulating somatostatin and insulin production
IL118376A0 (en) 1996-05-22 1996-09-12 Univ Ben Gurion Polysaccharide sponges for cell culture and transplantation
AU724745B2 (en) 1996-06-24 2000-09-28 Vivorx Pharmaceuticals, Inc. Methods for the isolation and proliferation of insulin-secreting cells
JP2001512689A (ja) 1997-08-11 2001-08-28 カイロン コーポレイション T細胞を遺伝子改変するための方法
CA2221195A1 (en) 1997-11-14 1999-05-14 Chantal E. Holy Biodegradable polymer matrix
US6143293A (en) 1998-03-26 2000-11-07 Carnegie Mellon Assembled scaffolds for three dimensional cell culturing and tissue generation
IL124957A0 (en) 1998-06-16 1999-01-26 Univ Ben Gurion Active ingredient delivery systems and devices based on porous matrices
US6242666B1 (en) 1998-12-16 2001-06-05 The Scripps Research Institute Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
US8778899B2 (en) 1999-06-01 2014-07-15 Sarah Ferber Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
US6774120B1 (en) * 1999-06-01 2004-08-10 Sarah Ferber Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
US6716824B1 (en) 1999-10-22 2004-04-06 F. Charles Brunicardi Treatment of pancreatic adenocarcinoma by cytotoxic gene therapy
US6759039B2 (en) 2000-06-30 2004-07-06 Amcyte, Inc. Culturing pancreatic stem cells having a specified, intermediate stage of development
US7214371B1 (en) 2000-09-01 2007-05-08 Ben-Gurion University Of The Negev Research & Development Authority Tissue engineered biografts for repair of damaged myocardium
WO2003020894A2 (en) 2001-08-31 2003-03-13 Joslin Diabetes Center, Inc. Insulin related transcription factor and uses thereof
US20050053588A1 (en) 2001-10-18 2005-03-10 Li Yin Conversion of liver stem and progenitor cells to pancreatic functional cells
US7722894B2 (en) 2001-10-22 2010-05-25 Massachusetts Institute Of Technology Biodegradable polymer
GB2399823B (en) 2001-12-07 2006-02-15 Geron Corp Islet cells from primate pluripotent stem cells
US7029915B2 (en) * 2002-02-22 2006-04-18 University Of Florida Research Foundation, Inc. Method for differentiating rat hepatic stem cells to insulin-producing cells
GB0206357D0 (en) 2002-03-18 2002-05-01 Univ Bath Cells
JP4136434B2 (ja) 2002-04-17 2008-08-20 進 清野 インスリン産生細胞の誘導
WO2003102171A1 (en) 2002-05-28 2003-12-11 Becton, Dickinson And Company Expansion and transdifferentiation of human acinar cells
CA2524356C (en) 2003-05-05 2015-03-10 Smadar Cohen Injectable cross-linked polymeric preparations and uses thereof
EP1624898A1 (en) 2003-05-12 2006-02-15 Sarah Ferber Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
WO2005005607A2 (en) 2003-06-30 2005-01-20 Lifescan, Inc. Seeding pancreatic cells on porous matrices
EP1670900A4 (en) 2003-08-27 2008-06-11 Stemcells California Inc ENHANCED PANCREATIC STEM CELL AND PRECURSOR CELL POPULATIONS AND METHOD OF IDENTIFYING, INSULATING AND ENRICHING SUCH POPULATIONS
CA2548464C (en) 2003-12-09 2013-02-12 Ben-Gurion University Of The Negev Research And Development Authority Pulse-medium perfusion bioreactor with improved mass transport for multiple 3-d cell constructs
EP1784481A1 (en) 2004-08-25 2007-05-16 Technion Research And Development Foundation, Ltd. Methods of generating embryoid bodies using three dimensional scaffolds
WO2006092799A1 (en) 2005-03-02 2006-09-08 Polyrizon Ltd. Method for removal of toxins from mucosal membranes
EP1856246B1 (en) 2005-03-07 2015-07-15 Technion Research & Development Foundation Limited Natural tissue-derived decellularized matrix and methods of generating and using same
US7517856B2 (en) 2005-10-11 2009-04-14 Ben-Gurion University Of The Negev Research And Development Authority Bioconjugates comprising sulfated polysaccharides and their uses
CA2658180A1 (en) * 2006-07-19 2008-01-31 University Of Florida Research Foundation, Inc. Compositions for reprogramming a cell and uses therefor
US9127254B2 (en) 2006-12-18 2015-09-08 Ben-Gurion University Of The Negev Research And Development Authority Scaffolding for tissue regeneration or repair
EP2176400B1 (en) 2007-07-11 2015-10-14 Technion Research & Development Foundation Ltd. Encapsulated mesenchymal stem cells and uses thereof
IL187707A0 (en) 2007-11-27 2008-11-03 Univ Ben Gurion Alginate scaffold in hepatectomy
WO2009126927A2 (en) * 2008-04-11 2009-10-15 Joslin Diabetes Center, Inc. Methods of generating insulin-producing cells
US9683215B2 (en) 2008-08-22 2017-06-20 President And Fellows Of Harvard College Methods of reprogramming cells
IN2012DN01268A (enExample) 2009-08-02 2015-05-15 Univ Tokyo Womens Medical
LT2494039T (lt) * 2009-10-31 2019-07-25 Genesis Technologies Limited Ląstelių perprogramavimo būdai ir jų panaudojimas
JP2011223993A (ja) 2010-03-30 2011-11-10 Kumamoto Univ 幹細胞の分化誘導方法
WO2011159726A2 (en) 2010-06-14 2011-12-22 The Scripps Research Institute Reprogramming of cells to a new fate
US9499793B2 (en) 2011-08-09 2016-11-22 Yeda Research And Development Co. Ltd. Downregulation of miR-7 for promotion of beta cell differentiation and insulin production
EP2816964B1 (en) 2012-02-21 2023-12-27 Ben-Gurion University of The Negev Research and Development Authority Hydrogel system comprising spatially separated bioactive polypeptides
EP2938347A4 (en) 2012-12-30 2016-08-10 Hadasit Med Res Service USE OF ALGINATE COMPOSITIONS TO PREVENT OR PREVENT LIVER DAMAGE THROUGH HEPATOTOXIC
KR102668827B1 (ko) 2013-05-08 2024-05-27 인리젠 단리된 신장 세포를 포함하는 오가노이드 및 이의 용도
KR102181336B1 (ko) * 2013-06-13 2020-11-24 오르제네시스 엘티디. 세포 집단, 이의 전환분화 방법 및 이용 방법
WO2015125147A1 (en) 2014-02-20 2015-08-27 B. G. Negev Technologies And Applications Ltd Anionic polyplexes for use in the delivery of nucleic acids
WO2015184313A1 (en) 2014-05-30 2015-12-03 Secant Medical, Inc. Water-mediated preparations of polymeric materials
EP3149026B1 (en) 2014-06-02 2025-03-05 B.G. Negev Technologies and Applications Ltd. Site-selective modification of polysaccharides and applications thereof
MA41296A (fr) 2014-12-30 2017-11-07 Orgenesis Ltd Procédés de transdifférenciation et procédés d'utilisation de ceux-ci
US11123404B2 (en) 2016-01-07 2021-09-21 B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University Methods for generating immunotolerant responses
US20170290954A1 (en) 2016-04-07 2017-10-12 B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University Compositions and methods for treating spinal cord injury
WO2017175229A1 (en) 2016-04-07 2017-10-12 B.G. Negev Technologies And Applications Ltd. Polysaccharide compositions and uses thereof
WO2018207179A1 (en) 2017-05-08 2018-11-15 Orgenesis Ltd. Transdifferentiated cell populations and methods of use thereof

Similar Documents

Publication Publication Date Title
Lahmy et al. MiRNA-375 promotes beta pancreatic differentiation in human induced pluripotent stem (hiPS) cells
Rossignoli et al. Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood
Bajpai et al. Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates
CN104520424B (zh) 使用合成的信使rna无饲养细胞地衍生人类诱导性多能干细胞
Zwi-Dantsis et al. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients
US9926532B2 (en) Method of generating induced pluripotent stem cells and differentiated cells
Xu et al. The combined expression of Pdx1 and MafA with either Ngn3 or NeuroD improves the differentiation efficiency of mouse embryonic stem cells into insulin-producing cells
Gorabi et al. TBX18 transcription factor overexpression in human‐induced pluripotent stem cells increases their differentiation into pacemaker‐like cells
JP6342115B2 (ja) 再プログラム化多能性細胞の作製
US10604738B2 (en) Transcription factor mediated programming towards megakaryocytes
WO2014190361A2 (en) Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna
Spinelli et al. Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs)
Davoodian et al. Let-7f microRNA negatively regulates hepatic differentiation of human adipose tissue-derived stem cells
Shaer et al. miR-375 induces human decidua basalis-derived stromal cells to become insulin-producing cells
Chang et al. Feeder-independent derivation of induced-pluripotent stem cells from peripheral blood endothelial progenitor cells
Kim et al. Stable cell adhesion affects mesenchymal stem cell sheet fabrication: effects of fetal bovine serum and human platelet lysate
Mohamed et al. Umbilical cord tissue as a source of young cells for the derivation of induced pluripotent stem cells using non-integrating episomal vectors and feeder-free conditions
JP2019103393A (ja) 骨格筋幹細胞誘導方法
CN107893049A (zh) 产生诱导多能干细胞和分化细胞的方法
JP2021176315A (ja) 神経系細胞の作製方法
Meivar-Levy et al. Human liver cells expressing albumin and mesenchymal characteristics give rise to insulin‐producing cells
US20140073049A1 (en) Induced pluripotent stem cells prepared from human kidney-derived cells
Dick et al. Two new protocols to enhance the production and isolation of human induced pluripotent stem cell lines
Eberle et al. Engineered MSCs from patient-specific iPS cells
WO2014129628A1 (ja) 多能性幹細胞から膵ランゲルハンス島を製造する方法